ESR1 and cancer: Interestingly, estrogen signaling can promote intratumoral immunosuppressive activity of estrogen receptor (ER)–positive Ly6CloLy6G+ myeloid cells and enhance cancer progression in mice, even in ER-negative tumors (Svoronos et al., 2017).